BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3566228)

  • 1. [Toxicity of rubomycin 13-cyclohexylidene hydrazone].
    Stepanova ES; Vertogradova TP; Shevniuk LA; Shepelevtseva NG; Gol'dberg LE
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):42-7. PubMed ID: 3566228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and antitumor properties of rubomycin 13-cyclohexylidene hydrazone].
    Tarasova VE; Ul'ianova LA; Povarov LS; Odnoralets EN
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):27-31. PubMed ID: 3566226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the cardiotoxicity of the anthracycline antibiotics, rubomycin, carminomycin and dihydrocarminomycin, in experiments on white mice].
    Shepelevtseva NG; Belova IP; Vertogradova TP; Gol'dberg LE
    Antibiotiki; 1978 Jan; 23(1):78-87. PubMed ID: 623453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the toxicity of carminomycin 13-cyclohexylidenhydrazone].
    Shepelevtseva NG; Vertogradova TP; Belova IP; Gol'dberg LE
    Antibiotiki; 1983 Feb; 28(2):90-5. PubMed ID: 6838184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitroxyl derivatives of rubomycin].
    Emanuél' NM; Konovalova NP; D'iachkovskaia RF; Denisova LK
    Antibiotiki; 1982 Nov; 27(11):811-5. PubMed ID: 7181462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the myelotoxic action of rubomycin, adriamycin and carminomycin by their delayed effects in an experiment].
    Fursov SE; Novitskiĭ VV; Fedorenko EN; Gol'dberg ED
    Antibiot Med Biotekhnol; 1985 Apr; 30(4):284-8. PubMed ID: 4026249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of hemopoiesis inhibition and recovery after the administration of carminomycin and rubomycin in an experiment].
    Novitskiĭ VV; Pichugina TV; Gol'dberg ED
    Antibiotiki; 1984 Jun; 29(6):437-41. PubMed ID: 6476806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative pathomorphological study of the experimental action of carminomycin and rubomycin on the heart].
    Vinogorova GF; Khokhlova MP; Khanykova OK
    Antibiotiki; 1978 Oct; 23(10):931-4. PubMed ID: 708004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production and antineoplastic activity of new asymmetric azines on the rubomycin base].
    Tarasova VE; Ul'ianova LA; Iudina OI; Gol'dberg LE; Povarov LS; Olsuf'eva EN; Bychkova EN; Shepelevtseva NG
    Antibiot Khimioter; 1990 Apr; 35(4):21-4. PubMed ID: 2383140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
    Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS
    Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dependence of the toxicity of the antineoplastic antibiotics rubomycin and carminomycin, on the age and sex of white mice and rats].
    Gol'dberg LE; Filippos'iants ST
    Antibiotiki; 1976 Oct; 21(10):904-10. PubMed ID: 999239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use].
    Lichinitser MR; Syrkin AB
    Antibiotiki; 1976 Nov; 21(11):1030-2. PubMed ID: 1020931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs.
    Syrkin AB; Kiselev AV
    Oncology; 1980; 37 Suppl 1():67-70. PubMed ID: 6935578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and antitumor properties of 3'-desamino-3'-dimethylformamidinorubomycin].
    Povarov LS; Ul'ianova LA; Tarasova VE; Odnoralets EN; Iudina OI
    Antibiot Khimioter; 1988 Jun; 33(6):448-52. PubMed ID: 3421770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Olsuf'eva EN; Averbukh LA
    Antibiotiki; 1981 Nov; 26(11):813-6. PubMed ID: 6895688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin].
    Bogush TA; Sitdikova SM
    Antibiotiki; 1984 Jun; 29(6):446-50. PubMed ID: 6476808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and antitumor action of 14-N-substituted derivatives of rubomycin and karminomycin].
    Olsuf'eva EN; Povarov LS; Salimova EI; Volkolupova OP; Makukho LV
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):254-9. PubMed ID: 3631931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential anticancer agents--nitroxyl derivatives of Rubomycin.
    Emanuel NM; Konovalova NP; Diatchkovskaya RF
    Neoplasma; 1985; 32(3):285-92. PubMed ID: 4022191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of doxorubicin on animals in multiple intravenous administration].
    Shepelevtseva NG; Vertogradova TP; Shevniuk LA; Filippos'iants ST; Stepanova ES
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):768-74. PubMed ID: 3789687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the anthracycline antineoplastic antibiotics, rubomycin and carminomycin, on the glycogen and nucleic acid content in the myocardium of white mice].
    Shepelevtseva NG
    Antibiotiki; 1977 Jun; 22(6):553-7. PubMed ID: 883801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.